TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,512 | -82.7% | 281 | -70.3% | 0.00% | – |
| Q2 2023 | $14,516 | +4.1% | 945 | +52.4% | 0.00% | – |
| Q1 2023 | $13,944 | -13.4% | 620 | -19.1% | 0.00% | – |
| Q4 2022 | $16,109 | -15.2% | 766 | -1.3% | 0.00% | – |
| Q3 2022 | $19,000 | +5.6% | 776 | +3.2% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 752 | +5.9% | 0.00% | – |
| Q1 2022 | $18,000 | -18.2% | 710 | -0.1% | 0.00% | – |
| Q4 2021 | $22,000 | +29.4% | 711 | -1.7% | 0.00% | – |
| Q3 2021 | $17,000 | +750.0% | 723 | +343.6% | 0.00% | – |
| Q2 2021 | $2,000 | -50.0% | 163 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | 0.0% | 163 | 0.0% | 0.00% | – |
| Q4 2020 | $4,000 | – | 163 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
| Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
| Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
| GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
| ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
| HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
| MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
| Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
| Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |